Consumer Information for: RAN-OLANZAPINE
Consumer Information
Information about the product including what the product is used for, dosage, warnings, proper use and side effects. This summary will not tell you everything about the product. Contact your healthcare professional if you have any questions about the product.
What the medication is used for
RAN-Olanzapine are used to treat symptoms of schizophrenia
and related psychotic disorders as well as those of bipolar
disorder.
Your doctor may have prescribed RAN-Olanzapine for another
reason. Ask your doctor if you have any questions about why
RAN-Olanzapine has been prescribed for you.
What it does
RAN-Olanzapine belong to a group of medicines called antipsychotics. RAN-Olanzapine are used to treat symptoms of schizophrenia and related psychotic disorders as well as those of bipolar disorder. Schizophrenia may cause symptoms such as hallucinations (e.g. hearing, seeing, or sensing things which are not there), delusions, unusual suspiciousness, feeling withdrawn, lack of emotions. People with schizophrenia may also feel depressed, anxious or tense. Signs and symptoms of bipolar mania include but are not limited to: feeling invincible or all powerful, inflated self-esteem, racing thoughts, easily lose your train of thought, overreaction to what you see or hear, misinterpretation of events, speeded-up activity, talking very quickly, talking too loudly, or talking more than usual, decreased need for sleep, and poor judgment.
When it should not be used
Do not take RAN-Olanzapine if you have had an allergic reaction to RAN-Olanzapine or any of the ingredients listed in the “What the nonmedicinal ingredients are” section of this leaflet. Signs of allergic reaction may include a skin rash, itching, shortness of breath or swelling of the face, lips or tongue.
What the medicinal ingredient is
RAN-Olanzapine tablets contain the active ingredient called olanzapine.
What the non-medicinal ingredients are
RAN-Olanzapine tablets contain the following inactive ingredients: lactose monohydrate, hydroxypropyl cellulose, cellulose microcrystalline, crospovidone, magnesium stearate, polyvinyl alcohol, polyethylene glycol, titanium dioxide, talc, and indigo carmine (for the 15 mg only).
What dosage form it comes in
RAN-Olanzapine tablets are available in 2.5 mg, 5 mg, 7.5 mg, 10 mg, and 15 mg strengths.
Warnings and precautions
Serious Warnings and Precautions
Studies with various medicines of the group to which olanzapine belongs, when used in elderly patients with dementia have been associated with an increased rate of death. RAN-Olanzapine are not indicated in elderly patients with dementia.
BEFORE starting RAN-Olanzapine and to get the best possible treatment, be sure to tell your doctor if you:
- are pregnant or plan to become pregnant
- are breast-feeding or plan on breast-feeding
- have had an allergic reaction to any medicine which you
- have taken previously to treat your current condition
- have diabetes or a family history of diabetes
- have a history of any problems with the way your heart beats or have any heart problems
- have a history of stroke or high blood pressure
- have risk factors for developing blood clots such as: a family history of blood clots, age over 65, smoking, obesity, recent major surgery (such as hip or knee replacement), immobility due to air travel or other reason, or take oral contraceptives ("The Pill").
- are a smoker
- have ever had blackouts or seizures
- are taking any other medicines (prescriptions or over-thecounter medicines)
- drink alcoholic beverages or use drugs
- exercise vigorously or work in hot or sunny places
- have a history of liver problems, hepatitis or yellowing of the eyes and skin (jaundice)
- have prostate problems
- have intestinal congestion (paralytic ileus)
- have raised pressure within the eye (glaucoma)
- suffer from lactose intolerance because RAN-Olanzapine contain lactose
Effects on Newborns:
In some cases, babies born to a mother taking RAN-Olanzapine during pregnancy have experienced symptoms that are severe and require the newborn to be hospitalized. Sometimes, the symptoms may resolve on their own. Be prepared to seek immediate emergency medical attention for your newborn if they have difficulty breathing, are overly sleepy, have muscle stiffness, or floppy muscles (like a rag doll), are shaking, or are having difficulty feeding.
Interactions with this medication
Tell all doctors, dentists and pharmacists who are treating you
that you are taking RAN-Olanzapine.
Tell your doctor or pharmacist that you are taking RANOlanzapine
before you start taking any new medicines.
A combination of RAN-Olanzapine with the following medicines
might make you feel drowsy:
- medicines taken for anxiety or to help you sleep
- medicines taken for depression.
You should tell your doctor if you are taking fluvoxamine (antidepressant), ketoconazole (antifungal) or ciprofloxacin (antibiotic), as these medicines may lead to higher concentrations of olanzapine in your blood.
You should also tell your doctor if you are taking carbamazepine as it may lead to lower concentrations of RAN-Olanzapine in your blood, making RAN-Olanzapine less effective.
Only take other medicines while you are on RAN-Olanzapine if your doctor tells you that you can. DO NOT give RANOlanzapine to anyone else. Your doctor has prescribed it for you and your condition.
Proper use of this medication
Usual Dose
The most important thing about taking RAN-Olanzapine is to
take it the way your doctor has prescribed - the right dose, every
day. Your doctor has decided on the best dosage for you based on
your individual situation and needs. Your doctor may increase or
decrease your dose depending on your response.
Although RAN-Olanzapine cannot cure your condition, it can
help relieve your symptoms. If your symptoms improve or
disappear, it is probably because your treatment is working.
Studies have shown that, after coming off medication, a relapse
of symptoms occurs in about 2 out of 3 patients and is more than
double that of patients staying on their medication. That is why it
is so important to keep taking RAN- Olanzapine, even after your
symptoms have improved or disappeared. RAN-Olanzapine
should be taken for as long as you and your doctor believe it is
helping you.
Proper Handling Instructions:
RAN-Olanzapine tablets should be swallowed whole with aglass
of water. RAN-Olanzapine tablets can be taken with or without
food.
Overdose
Show the health care practitioner your box or bottle of tablets. Do this even if there are no signs of discomfort or poisoning. The most common signs if you have taken too much RANOlanzapine are drowsiness and slurred speech.
Missed Dose
Take your prescribed dose at the same time each day. If you miss a dose of RAN-Olanzapine by a few hours, take the dose when you remember. If most of the day has passed, wait until your next scheduled dose and try not to miss any more. Do not take 2 doses at once
Side effects and what to do about them
Like other medicines, RAN-Olanzapine can cause some side effects. These side effects are most likely to be minor and temporary. However, some may be serious and need medical attention. Many of the side effects are dose related, so it is important not to exceed your prescribed dose. The most common side effects of RAN-Olanzapine are:
- drowsiness
- weight gain
- dizziness
- increased appetite
- fluid retention
- constipation
- dry mouth
- feeling of restlessness (akathisia)
Because some people experience drowsiness, you should avoid driving a car or operating machinery until you know how RANOlanzapine affects you. Some people may feel dizzy in the early stages of treatment, especially when getting up from a lying or sitting position. This side effect usually passes after taking RANOlanzapine for a few days.
After prolonged use in women, medicines of this type can cause milk secretion or changes in the regularity of their monthly period. On rare occasions, after prolonged use in men, medicines of this type have been associated with breast enlargement. As well, abnormal liver function tests have been reported on occasion.
Your doctor should check your body weight before starting RAN-Olanzapine and continue to monitor it for as long as you are being treated.
Your doctor should take blood tests before starting RANOlanzapine. They will monitor blood sugar, and the number of infection fighting white blood cells. Your doctor should continue to monitor your blood for as long as you are being treated. If you have high levels of prolactin (measured with a blood test) and a condition called hypogonadism you may be at increased risk of breaking a bone due to osteoporosis. This occurs in both men and women.
Do not be alarmed by this list of possible side effects. You may not experience any of them. If any of these side effects are experienced, they are usually mild and temporary.
The following table is based on data from placebo-controlled clinical trials and from post-marketing data.
| Symptom / effect | Talk with your doctor or pharmacist only if severe | Talk with your doctor or pharmacist in all cases | Stop taking drug and seek immediate emergency medical attention |
|---|---|---|---|
| Common | |||
| New or worsening constipation | ✔ | ||
| Uncommon | |||
| Slow heartbeat 1 | ✔ | ||
| Rare | |||
| Liver inflammation (symptoms of fever, yellow skin or eyes, dark urine, weakness, abdominal pain, nausea, vomiting, loss of appetite, itching) 2 | ✔* | ||
| Low white blood cell count (symptoms of infection, such as cold, flu-like symptoms, fever, sore throat, as well as weakness or general feeling of unwellness) 2 | ✔ | ||
| Rash2 (see also Allergic Reaction below) | ✔ | ||
| Seizure [i.e. loss of consciouness with uncontrollable shaking (“fit”)] 2 | ✔* | ||
| Very rare | |||
| Allergic reaction (symptoms include skin rash, hives, swelling difficulty breathing) 2 | ✔* | ||
| Bruise easily, excessive bleeding 2 | ✔ | ||
| High fever, muscle rigidity, rapid heartbeat, profuse sweating, irregular pulse 1, 2 | ✔* | ||
| Increased thirst & hunger, frequent urination 1, 2 | ✔ | ||
| Muscle twitching or abnormal movements of the face or tongue2 | ✔* | ||
| Blood clots: swelling, pain and redness in an arm or leg that can be warm to touch. You may develop sudden chest pain, difficulty breathing and heart palpitations2 | ✔ | ||
| Pancreas inflammation (symptoms of severe abdominal pain, fever, nausea, vomiting) 2 | ✔ | ||
| Long-lasting (greater than 4 hours in duration) and painful erection of the penis2 | ✔ | ||
| Sudden weakness or numbness in the face, arms, or legs and speech or vision problems3 | ✔* | ||
| Very dark (“tea coloured”) urine, muscle tenderness and/or aching2 | ✔ | ||
1
Identified from the clinical trial database.
2
Identified from adverse events reported after release onto
market.
3
Identified from data from 5 placebo-controlled trials in elderly
patients with dementia-related psychosis.
*
If you think you have these side effects, it is important that you
seek medical advice from your doctor immediately.
This is not a complete list of side effects. For any unexpected
effects while taking RAN-Olanzapine, contact your doctor or
pharmacist.
How to store
All medicines should be kept out of reach of children.
RAN-Olanzapine should be stored in their original package
between 15 and 30 °C, in a dry place and out of direct light.
The expiry date of this medicine is printed on the package label.
Do not use the medicine after this date. If your doctor tells you to
stop taking RAN-Olanzapine or you find that they have passed
their expiry date, please return any left over medicine to your
pharmacist.
Reporting side effects
You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following three ways:
- Report online at www.healthcanada.gc.ca/medeffect
- Call toll-free at 1-866-234-2345
- Complete a Canada Vigilance Reporting Form and:
- Fax toll-free to 1-866-678-6789, or
- Mail to:
Canada Vigilance Program
Health Canada
Postal Locator 0701E
Ottawa ON K1A 0K9
Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffectTM Canada Web site at www.healthcanada.gc.ca/medeffect.
NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.
More information
This document, plus the full Product Monograph prepared for
health professionals, can be obtained by contacting the sponsor,
Ranbaxy Pharmaceuticals Canada Inc., at: 1-866-840-1340.
This leaflet was prepared by Ranbaxy Pharmaceuticals Canada
Inc.
Last revised: May 7, 2013
Related Drug Products
| Product name | DIN | Company name | Active ingredient(s) & strength |
|---|---|---|---|
| TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL | 02440180 | TARO PHARMACEUTICALS INC | BENZOYL PEROXIDE 5 % / W/W CLINDAMYCIN (CLINDAMYCIN PHOSPHATE) 1 % / W/W |